Lymph Nodes News and Research

RSS

Blood cancers may be caused by inactivation of a "tumor suppressor" gene

The discovery of a gene, called PRDM1, as a tumor suppressor sheds new light on the cause - and possible treatment - of diffuse large B-cell lymphomas (DLBCLs), a cancer of the blood's B-lymphocytes. DLBCLs comprise about 30 percent of non-Hodgkin's lymphomas.

25 Apr 2006

Genetic clue found to Chronic Fatigue Syndrome

According to researchers from the Centers for Disease Control and Prevention (CDC), in the United States, there may well be a genetic reason why some people develop Chronic Fatigue Syndrome (CFS).

24 Apr 2006

Bubonic plague confirmed in Los Angeles woman

Los Angeles County health officials have confirmed a case of bubonic plague in an adult woman. This is the first human case of plague in a Los Angeles County resident since 1984.

19 Apr 2006

Imaging of breast cancer diagnosed and treated with chemotherapy during pregnancy

Ultrasound provides a safe and accurate method of detecting breast cancers in pregnant women, as well as assessing response to chemotherapy, according to a study appearing in the April issue of Radiology.

13 Apr 2006

Advances in chemotherapy significantly reduce risk of disease recurrence in breast cancer patients

Recent advances in chemotherapy have significantly reduced the risk of disease recurrence and death in breast cancer patients whose tumors are not hormone sensitive, according to a study by researchers at Dana-Farber Cancer Institute and 10 other institutions.

13 Apr 2006

Benefit of chemotherapy in breast cancer depends on estrogen status of tumors

When it comes to chemotherapy treatment for women whose breast cancer has spread to their lymph nodes, the estrogen status of their tumors matters, says a team of researchers in the Journal of the American Medical Association.

11 Apr 2006

Estrogen-alone hormone therapy does not increase the risk of breast cancer in postmenopausal women

The results contrast with the previously reported WHI Estrogen plus Progestin Trial, which found an increase in breast cancer over about 5 years among those taking combined hormone therapy.

11 Apr 2006

Researchers reverse juvenile diabetes in animal model

Groundbreaking human clinical trial for type 1 diabetes to start this spring in Pittsburgh - Children's Hospital of Pittsburgh of UPMC researchers reverse juvenile diabetes in animal model; Phase 1 clinical trial approved by FDA.

4 Apr 2006

Multi-site vaccinations could protect against all four dengue viruses

An innovative new study explains, for the first time, the failure of previous attempts to vaccinate against the four known Dengue viruses, and it suggests a very simple solution - injecting the four vaccines simultaneously at different locations on the body.

4 Apr 2006

Transportation of prion protein across the intestinal mucosa of scrapie-susceptible and scrapie-resistant sheep

While newly published research confirms that under laboratory circumstances prion-protein can be absorbed across the gut, it also shows that this is unlikely to occur in real life.

4 Apr 2006

Gene key to infection-fighting immune cells identified

Every time the human body encounters a virus, bacteria or other infectious agent, immune cells called B-lymphocytes multiply in lymph nodes and then swing into action to fight off the intruders.

3 Apr 2006

Doctors able to predict recurrence of high-risk breast cancers

International researchers have developed a prediction model to assist doctors in determining the chance of recurrence of cancer in high-risk breast cancer patients who have undergone a mastectomy followed by radiation therapy.

3 Apr 2006

New evidence questions the simple link between prion proteins and vCJD

While newly published research confirms that under laboratory circumstances prion-protein can be absorbed across the gut, it also shows that this is unlikely to occur in real life.

30 Mar 2006

Weill Cornell researchers identify tumor-suppressor gene important to diffuse large B-cell lymphomas

Inactivation of a "tumor suppressor" gene could be a major cause of a class of blood cancers called diffuse large B-cell lymphomas, reports a team of researchers at the Weill Medical College of Cornell University.

30 Mar 2006

Positron emission tomography identifies esophageal cancer patients who will respond well to treatment

New research at Wake Forest University Baptist Medical Center shows that Positron Emission Tomography (PET) is more accurate than conventional imaging in identifying patients who have good responses to chemotherapy and radiation treatment - a finding that could one day help some patients avoid surgery.

22 Mar 2006

Lymph Nodes News and Research

Blood cancers may be caused by inactivation of a "tumor suppressor" gene

Genetic clue found to Chronic Fatigue Syndrome

Bubonic plague confirmed in Los Angeles woman

Imaging of breast cancer diagnosed and treated with chemotherapy during pregnancy

Advances in chemotherapy significantly reduce risk of disease recurrence in breast cancer patients

Benefit of chemotherapy in breast cancer depends on estrogen status of tumors

Estrogen-alone hormone therapy does not increase the risk of breast cancer in postmenopausal women

Researchers reverse juvenile diabetes in animal model

Multi-site vaccinations could protect against all four dengue viruses

Transportation of prion protein across the intestinal mucosa of scrapie-susceptible and scrapie-resistant sheep

Gene key to infection-fighting immune cells identified

Doctors able to predict recurrence of high-risk breast cancers

New evidence questions the simple link between prion proteins and vCJD

Weill Cornell researchers identify tumor-suppressor gene important to diffuse large B-cell lymphomas

Positron emission tomography identifies esophageal cancer patients who will respond well to treatment

HIV reveals another secret to its success

Interferon-producing killer dendritic cell speeds up immune reactions and fights cancer

Even asymptomatic former smokers should consider CT screening

Genzyme launches test to monitor Gleevec resistance

Source of crucial immune cell in the skin discovered - may lead to tumor immunotherapy

Immunology eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News